• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:金鑫,付尧,张艳莉.专利视角下全球钠-葡萄糖共转运蛋白2抑制剂研究现状分析[J].中国现代应用药学,2023,40(7):976-981.
JIN Xin,FU Yao,ZHANG Yanli.Research Progress Analysis on the Sodium-glucose Co-transporter 2 Inhibitors from the Perspective of Global Patent[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(7):976-981.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 932次   下载 576 本文二维码信息
码上扫一扫!
分享到: 微信 更多
专利视角下全球钠-葡萄糖共转运蛋白2抑制剂研究现状分析
金鑫1, 付尧2, 张艳莉1
1.吉林大学, 长春 130021;2.吉林大学第一医院重症医学科, 长春 130021
摘要:
目的 梳理全球钠-葡萄糖共转运蛋白2(sodium-glucose co-transporter,SGLT2)抑制剂相关专利的现状,探讨该领域技术的研究布局及发展趋势,为国内同行提供参考借鉴。方法 以全球SGLT2抑制剂相关专利为研究对象,通过Incopat数据平台对其进行计量学统计和分析。结果与结论 SGLT2抑制剂相关技术专利于2014年后开始迅速增加,现已进入平稳发展阶段。分类号A61K、A61P、C07D的专利申请相对活跃,全球热点主题分布在医用配置、化合物或药物制剂的特定治疗活性等方向,头部研发机构主要聚焦在关键中间体、半水合物、协同转运蛋白、心力衰竭等聚类关键词方面。
关键词:  钠-葡萄糖共转运蛋白2  抑制剂  专利布局  专利分析
DOI:10.13748/j.cnki.issn1007-7693.20222000
分类号:R977.1+5
基金项目:
Research Progress Analysis on the Sodium-glucose Co-transporter 2 Inhibitors from the Perspective of Global Patent
JIN Xin1, FU Yao2, ZHANG Yanli1
1.Jilin University, Changchun 130021, China;2.Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun 130021, China
Abstract:
OBJECTIVE To comb the current status of patents related to sodium-glucose co-transporter(SGLT2) in the world, and explore the research layout and development trend, to provide reference for domestic peers. METHODS Took the global SGLT-2 patents as the research object, and conduct metrological statistics and analysis based on the Incopat patent data. RESULTS & CONCLUSION SGLT2 inhibitor patents began to increase rapidly since 2014, and entered a steady stage now. A61K, A61P, C07D patent applications were relatively active, global topics were distributed in the direction of medical configuration, specific therapeutic activity of compounds or pharmaceutical preparations, etc. The head R&D institutions mainly focused on key intermediates, hemihydrate, cotransporters, heart failure and other clustering keywords.
Key words:  SGLT2  inhibitor  patent layout  patent analysis
扫一扫关注本刊微信